6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
28m ago	Appendix 4C and Quarterly Activities Report - March 2026
54m ago	Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
54m ago	ING completes share buyback and announces new programme of up to €1.0 billion
54m ago	argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

About

Verastem Inc (NASDAQ:VSTM) — investor relations, events, news, and company updates on 6ix.

Latest News

Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026

Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the SGO 2026 Annual Meeting on Women’s Cancers

Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026

Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers

Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates

Financials

Revenue

$30.91 M

Market Cap

$481.34 M

EPS

-3.02

Community Chat

Ask AI